TranXenoGen, Inc is a biotechnology company focused on developing methods for manufacturing its own therapeutic proteins, as well as generic biologicals. The Company's technology platform has multiple application potentials, including the generation of transgenic chickens for the manufacture of high volume therapeutic proteins, animal models for the study of disease, and high-throughput production of antibodies from genomic-derived targets for product identification. The first of Company's own therapeutic protein products is Anti-Neoplastic Urinary Protein, developed for the treatment of several types of cancer. The Company also intends to utilize its technology for the production of insulin and human serum albumin. The Company is also exploring licensing both its technology and products f... (Source: SEC reports)
Competitor - 1/8
Which company is more competitive with Texas Instruments?